Björn Cedermark

8.9k citations

88 papers · 6.5k indexed · 3 hit papers · h-index 37

Impact in

Oncology top 0.2%
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Colorectal Cancer Treatments and Studies
Surgery top 0.5%
- Colorectal and Anal Carcinomas
- Anorectal Disease Treatments and Outcomes

Papers in

Oncology 59
- Colorectal Cancer Surgical Treatments 34
- Colorectal Cancer Screening and Detection 18
Microbiology 1

Co-authors: T. Holm Hemming Johansson Bengt Glimelius Anna Martling L. E. Rutqvist Lars Påhlman Lars Erik Rutqvist Torbjörn Holm
Journals: British journal of surgery (15 papers)Cancer (7 papers)Diseases of the Colon & Rectum (3 papers)World Journal of Surgery (3 papers)European Journal of Surgical Oncology (3 papers)
Partner nations: Sweden United States United Kingdom

In The Last Decade

Björn Cedermark

86 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial 2017 · 395 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2017 The Lancet Oncology
2005 Journal of Clinical Oncology
1989 The Lancet

Peers

Countries citing papers authored by Björn Cedermark

Since Specialization

Citations

This map shows the geographic impact of Björn Cedermark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Cedermark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Cedermark more than expected).

Fields of papers citing papers by Björn Cedermark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Cedermark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Cedermark. The network helps show where Björn Cedermark may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Björn Cedermark, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Björn Cedermark Line = papers co-authored together Björn Cedermark links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Quality of Life after Potentially Curative Treatment for Locally Advanced Rectal Cancer Annals of Surgical Oncology ·G. Palmer, Anna Martling, Pernilla Lagergren, Björn Cedermark, Torbjörn Holm	2008	33
2	MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry European Radiology ·Michael R. Torkzad, Johan Lindholm, Anna Martling, Björn Cedermark, Bengt Glimelius, Lennart Blomqvist	2007	31
3	Loco-regional Recurrence from Colon Cancer: A Population-based Study Annals of Surgical Oncology ·Annika Sjövall, Fredrik Granath, Björn Cedermark, Bengt Glimelius, Torbjörn Holm	2006	94
4	Alterations of the SDHD gene locus in midgut carcinoids, Merkel cell carcinomas, pheochromocytomas, and abdominal paragangliomas Genes Chromosomes and Cancer ·Soili Kytölä, Brita Nord, Elisabeth Elder, Tobias Carling, Magnus Kjellman, Björn Cedermark, Claes Juhlin, Anders Höög, Jorma Isola, Catharina Larsson	2002	52
5	Comparative Genomic Hybridization Identifies Loss of 18q22-qter as an Early and Specific Event in Tumorigenesis of Midgut Carcinoids American Journal Of Pathology ·Soili Kytölä, Anders Höög, Brita Nord, Björn Cedermark, Tony Frisk, Catharina Larsson, Magnus Kjellman	2001	109
6	Malignant human renin producing paraganglionoma–localization with ¹²³I‐MIBG and treatment with ¹³¹I‐MIBG Clinical Endocrinology ·Stefan Arver, Hans Jacobsson, Björn Cedermark, Bertil Hamberger, G. E. F. Lundell, Lars Grimelius, Kerstin Brismar	1999	2
7	Well-being, general health and coping ability: 1-year follow-up of patients treated for colorectal and gastric cancer European Journal of Cancer Care ·Christina Forsberg, Björn Cedermark	1996	33
8	Multiple neuropetide immunoreactivities in a renin-producing human paraganglioma Cancer ·Gabriel Fried, Delgado-Sierra Gustavo, Anders Höög, Stefan Arver, Björn Cedermark, Bertil Hamberger, Lars Grimelius, Björn Meister	1994	15
9	Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ. PubMed ·H. Schimmelpenning, Issei Sakata, Illyaskutty Neelofar, Lambert Skoog, Björn Cedermark, Takafumi Kamei	1992	36
10	Adjuvant tamoxifen in early-stage breast cancer: effects on intercurrent morbidity and mortality. Journal of Clinical Oncology ·Tommy� Fornander, L. E. Rutqvist, Björn Cedermark, Ulla Glas, A Mattsson, Lambert Skoog, A Somell, Tolle Theve, Nils Wilking, J Askergren	1991	32
11	Randomized trial of adjuvant tamoxifen combined with postoperative radiation therapy or adjuvant chemotherapy in postmenopausal breast cancer Cancer ·Lars Erik Rutqvist, Björn Cedermark, Ulla Glas, Hemming Johansson, Sam Rotstein, Lambert Skoog, Anders Somell, Tolle Theve, Nils Wilking, J Askergren, G Kluger	1990	33
12	Implantable catheter system for long‐term intravenous chemotherapy Journal of Surgical Oncology ·Per Hall, Björn Cedermark, Jesper Swedenborg	1989	30
13	The clinical use of monoclonal antibodies, MAb 17-1A, in the treatment of patients with metastatic colorectal carcinoma Medical Oncology and Tumor Pharmacotherapy ·Håkan Mellstedt, Jan‐Erik Frödin, Peter Ragnhammar, Giuseppe Masucci, J. Shetye, Birger Christensson, Peter Biberfeld, Josh Makower, P. Pihlstedt, Björn Cedermark, Ulrika Harmenberg, B. Wahren, Åke Rieger, I Magnusson, Algirdas Šidlauskas, R Erwald	1989	12
14	The relationship between hormone receptor content and the effect of adjuvant tamoxifen in operable breast cancer. Journal of Clinical Oncology ·Lars Erik Rutqvist, Björn Cedermark, Tommy� Fornander, Ulla Glas, Hemming Johansson, Bo Nordenskjöld, S Rotstein, Lambert Skoog, A Somell, Tolle Theve	1989	36
15	Oral treatment with RU 41.740 (BiostimTM) in patients with advanced colorectal cancer: Influence on the blood lymphocyte population International Journal of Immunopharmacology ·Henric Blomgren, Muhammed Yasir Altunişik, Björn Cedermark, Tolle Theve, U Öhman	1989	4
16	Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: A summary of three randomized trials International Journal of Radiation OncologyBiologyPhysics ·Lars Erik Rutqvist, Björn Cedermark, Ulla Glas, H. Johansson, Sam Rotstein, Lambert Skoog, Anders Somell, Tolle Theve, J Askergren, Sten Friberg, Jan Bergström, B Blomstedt, Lars Räf, Claes Silfverswärd, Jerzy Einhorn	1989	106
17	Insulin and C-peptide co-localization in theβ granules of normal human pancreas and insulinomas Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·M. Kalina, Arin Ngamniyoma, Björn Cedermark, Ilan Hammel	1989	2
18	Expression of tachykinins by ileal and lung carcinoid tumors assessed by combined in situ hybridization, immunocytochemistry, and radioimmunoassay Cancer ·A.E. Bishop, Q. Hamid, Caroline Adams, D. Bretherton‐Watt, Philip Jones, Paul Denny, G. W. H. Stamp, R. L. Hurt, Lars Grimelius, Anthony J. Harmar, Kyle Valentino, Björn Cedermark, S. Legon, M. A. Ghatei, S. R. Bloom, Julia M. Polak	1989	20
19	Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin ·(unknown), Hans G. Feichtinger, Kurt Werner Schmid, Reiner Fischer‐Colbrie, Lars Grimelius, Björn Cedermark, Mauro Papotti, Gianni Bussolati, Hans Winkler	1987	51
20	The Stockholm trial on adjuvant tamoxifen in early breast cancer Breast Cancer Research and Treatment ·Lars Erik Rutqvist, Björn Cedermark, Ulla Glas, Hemming Johansson, Bo Nordenskjöld, Lambert Skoog, Anders Somell, Tolle Theve, Sten Friberg, J Askergren	1987	98

About Björn Cedermark

Björn Cedermark is a scholar working on Oncology, Microbiology, Cancer Research, Surgery and Radiology, Nuclear Medicine and Imaging, having authored 88 papers that have together received 6.5k indexed citations. Recurring topics across this work include Colorectal Cancer Surgical Treatments (34 papers), Colorectal and Anal Carcinomas (28 papers), Colorectal Cancer Screening and Detection (18 papers), Breast Cancer Treatment Studies (11 papers), Neuroendocrine Tumor Research Advances (10 papers), Estrogen and related hormone effects (9 papers), Adrenal and Paraganglionic Tumors (7 papers) and Gastric Cancer Management and Outcomes (6 papers). The work is most often cited by research in Oncology (5.0k citations), Surgery (3.5k citations), Cancer Research (769 citations), Obstetrics and Gynecology (260 citations) and Pulmonary and Respiratory Medicine (1.0k citations). Björn Cedermark has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include T. Holm, Hemming Johansson, Bengt Glimelius, Anna Martling, L. E. Rutqvist, Lars Påhlman, Lars Erik Rutqvist, Torbjörn Holm, Lambert Skoog and Joakim Folkesson. Their work appears in journals such as British journal of surgery, Cancer, Diseases of the Colon & Rectum, World Journal of Surgery and European Journal of Surgical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact